MX9307834A - Derivados de 3-(quinolein-6-il-metil)-4h-imidazol-4-ona, su preparacion ysu aplicacion en terapeutica. - Google Patents

Derivados de 3-(quinolein-6-il-metil)-4h-imidazol-4-ona, su preparacion ysu aplicacion en terapeutica.

Info

Publication number
MX9307834A
MX9307834A MX9307834A MX9307834A MX9307834A MX 9307834 A MX9307834 A MX 9307834A MX 9307834 A MX9307834 A MX 9307834A MX 9307834 A MX9307834 A MX 9307834A MX 9307834 A MX9307834 A MX 9307834A
Authority
MX
Mexico
Prior art keywords
imidazol
derivatives
methyl
preparation
quinolein
Prior art date
Application number
MX9307834A
Other languages
English (en)
Inventor
Gerard Cremer
Jean Claude Muller
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of MX9307834A publication Critical patent/MX9307834A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención tiene por objeto derivados de3-quinolen-6-il-metil)-4H-imidazol-4-ona, su preparación y su aplicaciónen terapéutica. Los compuestos de la invención puedenforma de bases libres o bajo forma de sales orgánicas o inorgánicasfarmacéuticamente aceptables.
MX9307834A 1992-12-14 1993-12-10 Derivados de 3-(quinolein-6-il-metil)-4h-imidazol-4-ona, su preparacion ysu aplicacion en terapeutica. MX9307834A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9215038A FR2699174B1 (fr) 1992-12-14 1992-12-14 Dérivés de 3-(quinoléin-6-yl-méthyl)-4H-imidazol-4-one, leur préparation et leur application en thérapeutique.

Publications (1)

Publication Number Publication Date
MX9307834A true MX9307834A (es) 1995-01-31

Family

ID=9436560

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9307834A MX9307834A (es) 1992-12-14 1993-12-10 Derivados de 3-(quinolein-6-il-metil)-4h-imidazol-4-ona, su preparacion ysu aplicacion en terapeutica.

Country Status (17)

Country Link
EP (1) EP0604259A1 (es)
JP (1) JP2548511B2 (es)
KR (1) KR940014386A (es)
CN (1) CN1095378A (es)
AU (1) AU5233893A (es)
CA (1) CA2111302A1 (es)
CZ (1) CZ273293A3 (es)
FI (1) FI935575A (es)
FR (1) FR2699174B1 (es)
HU (1) HUT69701A (es)
IL (1) IL108011A0 (es)
MX (1) MX9307834A (es)
NO (1) NO934566L (es)
NZ (1) NZ250441A (es)
PL (1) PL301461A1 (es)
SK (1) SK141193A3 (es)
ZA (1) ZA939333B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716196B1 (fr) * 1994-02-16 1996-04-05 Synthelabo Dérivés de 8-[2-(1H-tétrazol-5-yl) phényl] quinoléine, leur préparation et leur application en thérapeutique.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2683819B1 (fr) * 1991-10-28 1994-02-11 Synthelabo Derives de quinoleine, leur procede de preparation et leur application en therapeutique.
US5478832A (en) * 1992-05-08 1995-12-26 The Green Cross Corporation Quinoline compounds

Also Published As

Publication number Publication date
CZ273293A3 (en) 1994-07-13
HUT69701A (en) 1995-09-28
NO934566L (no) 1994-06-15
AU5233893A (en) 1994-06-23
JP2548511B2 (ja) 1996-10-30
CA2111302A1 (en) 1994-06-15
KR940014386A (ko) 1994-07-18
ZA939333B (en) 1994-08-25
SK141193A3 (en) 1995-02-08
CN1095378A (zh) 1994-11-23
JPH06199841A (ja) 1994-07-19
HU9303560D0 (en) 1994-04-28
FI935575A0 (fi) 1993-12-13
IL108011A0 (en) 1994-04-12
NO934566D0 (no) 1993-12-13
NZ250441A (en) 1995-04-27
FR2699174A1 (fr) 1994-06-17
EP0604259A1 (fr) 1994-06-29
FI935575A (fi) 1994-06-15
PL301461A1 (en) 1994-06-27
FR2699174B1 (fr) 1995-01-20

Similar Documents

Publication Publication Date Title
NO914667L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
FI954718A (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
ES2081397T3 (es) O-metil derivados de azitromicina a, procedimiento y productos intermedios para su preparacion, y uso de los mismos en la preparacion de productos farmaceuticos.
MX9300014A (es) Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su elaboracion.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO894630L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
ATE130290T1 (de) Derivate der 4-hydroxy-buttersäure.
DK0476229T3 (da) Bøjlelås med drejelåsning
FI933472A (fi) Peptider med foermaoga att inhibera effekten av HIV-proteas, deras framstaellning och terapeutiska anvaendning
NO904986D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater.
NO910935L (no) Fremgangsmaate for fremstilling av terapeutisk aktive c-bundne pyrazol-derivater.
NO910395L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 4-isoxazolcarboxamidderivater.
NO953370D0 (no) Anvendelse av riluzol ved behandling av neuro-AIDS
NO893088L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme somatostatinlignende cykliske peptidforbindelser.
MX9302116A (es) Compuestos azabiciclo.
NO891723L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
ITMI911470A1 (it) N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
MX9307834A (es) Derivados de 3-(quinolein-6-il-metil)-4h-imidazol-4-ona, su preparacion ysu aplicacion en terapeutica.
NO914071D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO895220L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzenderivater.
ES2101747T3 (es) Penciclovir y famciclovir y derivados de guanina relacionados para el tratamiento de infecciones por vih-1.
NO913187L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO924151L (no) Komplekse salter av hematoporfyrin, derivater derav, fremgangsmaate for fremstilling samt terapeutisk anvendelse